2nd Nature Launches AI-Discovered Ingredients That Enable Healthier Formulations Without Compromising Taste Natural sweeteners and umami enhancers discovered in major crop side streams offer sugar and salt replacements GlobeNewswire January 21, 2026 CINCINNATI, Jan. 21, 2026 (GLOBE NEWSWIRE) — 2nd Nature, the proprietor of AgWaste Portal(TM), today announced the launch of its first AI-discovered functional […]

SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247 GlobeNewswire January 21, 2026 The QIDP designation will ensure at least 10 years of market exclusivity for SCY-247 following approval Recent articles highlight the growing threat from a rapidly spreading, multi-drug resistant, Candida auris fungal infection JERSEY CITY, N.J., Jan. 21,

Super League Announces 1-for-12 Reverse Split GlobeNewswire January 21, 2026 SANTA MONICA, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), a leader in playable media trusted by global brands to reach and activate gaming audiences through playable ads and gamified content, announced today a reverse stock split of its issued

Legend Biotech to Present CARVYKTI(R) Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use GlobeNewswire January 21, 2026 Six poster presentations highlight CARVYKTI(R) efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, reflecting a maturing and expanding body of evidence SOMERSET, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ:

Amanda Demanda Injury Lawyers Appoints Miriam Fresco Agrait, Esq. as Managing Partner GlobeNewswire January 21, 2026 MIAMI, Jan. 21, 2026 (GLOBE NEWSWIRE) — Amanda Demanda Injury Lawyers announced that Miriam Fresco Agrait, Esq. has joined the firm as Managing Partner, marking a significant milestone in the firm's continued growth and expansion. A Board Certified Civil

Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore's gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”) GlobeNewswire January 21, 2026 ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus

LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel GlobeNewswire January 21, 2026 NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the appointment Dr. Minako Pazdera as

Microchip Introduces 600V Gate Driver Family for High-Voltage Power Management Applications The new gate driver family supports up to 600V operation, expanding the company's high-voltage power solutions GlobeNewswire January 21, 2026 CHANDLER, Ariz., Jan. 21, 2026 (GLOBE NEWSWIRE) — To meet the demanding needs of high-voltage power management applications, Microchip Technology (Nasdaq: MCHP) today announces

American Heart Association and Centre for Neuro Skills Deepen Relationship to Advance Stroke and Brain Injury Care Multi-year Sponsorship Expands Across Texas and California with Educational Resources, Community Leadership and Patient Support GlobeNewswire January 21, 2026 BAKERSFIELD, Calif. and AUSTIN, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) — Centre for Neuro Skills (CNS) and the American

Horizon Land Company, LLC Appoints Drew Odabashian as Co-CEO Promotion reflects continued success of the vertically integrated manufactured housing operator as the firm approaches its 20-year anniversary GlobeNewswire January 21, 2026 CROFTON, Md., Jan. 21, 2026 (GLOBE NEWSWIRE) — Horizon Land Company, LLC (“Horizon”), a vertically integrated owner-operator of manufactured housing communities, has announced the